Sort by:

• Highly Influential Citations
• Citations
• Acceleration
• Velocity
• Recency

Learn More

Cachexia of malignancy: potential role of insulin in nutritional management.

• Philip S. Schein, D F Kisner, Dirk Haller, Melvln Blecher, Marfllt Hamosh
• Cancer
• 1979

Patients manifesting the syndrome of cachexia of malignancy exhibit an abnormal diabetic glucose tolerance. In our patients this has been correlated with a marked resistance to administered insulin,… (More)

Phase I clinical trial with ametantrone (NSC-287513).

• Martine J. Piccart, Marcel Rozencweig, +5 authors Yvon Kenis
• European journal of cancer & clinical oncology
• 1981

Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma

• Randal Leavitt, Voravit Ratanatharathorn, +7 authors Eric M. Bonnem
• Seminars in oncology
• 1987

Interferon-alpha therapy of renal cancer.

• James A. Neidhart, M M Gagen, +4 authors D F Kisner
• Cancer research
• 1984

Thirty-three patients with renal cancer began treatment with human lymphoblastoid interferon (Wellferon) between August 1982 and February 1983. Interferon was administered as an i.m. injection at a… (More)

Chemotherapy of large intestinal carcinoma. Current results and future prospects.

• Philip S. Schein, D F Kisner, John S. Macdonald
• Cancer
• 1975

Chemotherapy of advanced stages of large bowel cancer has until recently made little progress since the introduction of 5-FU 16 years ago. While survival is improved for patients who respond, 5-FU… (More)

Phase I clinical study of 9-hydroxy-2N-methyl-ellipticinium acetate (NSC-264137) administered on a 5-day i.v. schedule☆

• Pierre Dodion, Marcel Rozencweig, +5 authors Yvon Kenis
• European journal of cancer & clinical oncology
• 1982

Twenty-three patients with advanced solid tumors received 9-hydroxy-2N-methyl-ellipticinium acetate at a single daily i.v. dose of 15-80 mg/m2 for 5 consecutive days, repeated every 3 weeks. One… (More)

5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.

• John S. Macdonald, D F Kisner, Thomas B. Smythe, Paul V. Woolley, Lanette F Smith, Philip S. Schein
• Cancer treatment reports
• 1976

We report a phase II trial of 5-fluorouracil (5-FU), methyl-CCNU, and vincristine (FMV) combination chemotherapy in advanced colorectal carcinoma. Ten of 25 patients (40%) achieved an objective tumor… (More)

Phase I clinical trial with alpha 1,3,5- triglycidyl-s-triazinetrione (NSC-296934).

• Martine J. Piccart, Marcel Rozencweig, +6 authors Yvon Kenis
• European journal of cancer & clinical oncology
• 1981

Doxorubicin and interferon: rationale and clinical experience.

• Michael Green, Jason Speyer, +5 authors Franco M. Muggia
• Cancer treatment reviews
• 1985

• ‹
• 1
• ›